CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 5, 2009, Pages 642-644

  Tincati, Camilla ^a   Bellistri, Giusi M ^a   Casana, Maddalena ^a   Merlini, Esther ^a   Comi, Laura ^a   Bai, Francesca ^a   Sinigaglia, Elisabetta ^b   Cristina, Maurizio ^a   Carpani, Giovanni ^b   Bini, Teresa ^a   Monforte, Antonella D'Arminio ^a   Marchetti, Giulia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTERY MEDIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTIMA; LETTER; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENESCENCE; SMOKING; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADULT; APOPTOSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA;

EID: 68449084461     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181add695     Document Type: Letter

References (9)

1. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-1735.
2. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
3. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603-1608.
4. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004; 109(21 Suppl 1):II2-II10.
5. Coll B, Parra S, Alonso-Villaverde C, et al. The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke. 2007;38:2477-2484.
6. Douek DC. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 2003;5:172-177.
7. Lee KH, Feig C, Tchikov V, et al. The role of receptor internalization in CD95 signaling. EMBO J. 2006;25:1009-1023.
8. Paiardini M, Cervasi B, Albrecht H, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005;174:2900-2909.
9. Bofill M, Mocroft A, Lipman M, et al. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS. 1996;10:827-834.